R&D scientists in pharma and biotech are under pressure to identify new targets and biomarkers with fewer resources. This requires access, integration and analytics across many different data types including multi-omics, unstructured, and structured.
Eagle Genomics held a 40-minute webinar on 2 December 2015 "Unleashing the Power of Mulit-Omics Datasets for R&D". If you joined the Eagle Genomics' Webinar, we hope you gained some new insights into the issues and challenges of effectively integrating multi-omics datasets into R&D.
If you missed it, click on the link to submit your contact information to view a recording of the webinar.
Click here to Access the Recording of Eagle Genomics webinar.
Unleashing the power of multi-omics datasets for R&D
In the webinar, we reviewed:
- Two real-life examples of how pharma R&D use multi-omics data to achieve data-driven discovery
- Methods for integrating and seamlessly linking many different (omics and other) internal and external data sources
- New techniques in biodata curation leading to accelerated scientific analysis
Raminderpal Singh, Head of Business Development, Eagle Genomics
Will Spooner, CSO, Eagle Genomics
Glenn Proctor, CTO, Eagle Genomics
Abel Ureta-Vidal, CEO, Eagle Genomics